Chronic Lymphocytic Leukemia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

ICP-248 in Combination With Orelabrutinib in Treatment-na ïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Hematologic Malignancies Interventions: Drug: ICP-248; Drug: Orelabrutinib Sponsors: Beijing InnoCare Pharma Tech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials

Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia Stage A(0) Interventions: Other: Whole-food, plant-based diet Sponsors: University of California, San Diego Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL
Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma Interventions: Drug: Sonrotoclax; Drug: Zanubrutinib Sponsors: Institute of Hematology& Blood Diseases Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

Biological and Clinical Efficacy of Shingrix in Patients With CLL
Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; CLL-like MBL; Varicella-zoster Virus Reactivation Interventions: Biological: serologic response evaluation Sponsors: Gruppo Italiano Malattie EMatologiche dell ' Adulto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
Conditions: B-Cell Chronic Lymphocytic Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; B-Lymphocytic Leukemia, Chronic Interventions: Biological: Autologous HuCD19 ( Anti-CD19)CAR T cells; Drug: Cyclophosphamide; Drug: Fludarabine; Drug: Rituximab Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials

A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
Conditions: Chronic Lymphocytic Leukemia Sponsors: AbbVie Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Secondary Malignancy
Conditions: Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukaemia; Multiple Myeloma Interventions: Biological: Idecabtagene vicleucel; Biological: Lisocabtagene maraleucel Sponsors: Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies
Conditions: Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Transformed Chronic Lymphocytic Leukemia; Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory High Grade B-Cell Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Transformed Chronic Lymphocytic Leukemia; Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell L...
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma Interventions: Drug: Pirtobrutinib; Drug: Obinutuzumab Sponsors: Inhye Ahn; Loxo Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell Interventions: Behavioral: Individual Physical Activity Intervention (IPAI); Drug: Ibrutinib Sponsors: Janssen Cilag S.A.S. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma Interventions: Drug: Obinutuzumab; Drug: ABBV-453 Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials

AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
Conditions: Chronic Lymphocytic Leukemia Sponsors: Arbeitsgemeinschaft medikamentoese Tumortherapie Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials

Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Recurrent Transformed Chronic Lymphocytic Leukemia; Refractory Transformed Chronic Lymphocytic Leukemia; Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma; Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Biological: Nivolumab; Procedure: Positron Emission Tomography; Biological: Rituximab; Drug: Venetoclax Sponsors: Northwestern University; National Cancer Institute (NCI); Brist...
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

Preliminary Assessment of [18F]BL40 in PET/CT Scans
Conditions: Diffuse Large B-cell Lymphoma; Multiple Myeloma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Chronic Lymphocytic Leukemia; Waldenstr öm Macroglobulinemia Interventions: Diagnostic Test: 18F-BL40 PET/CT; Diagnostic Test: 18F-FDG PET/CT; Diagnostic Test: Routine Blood Draw - Phase 1 only Sponsors: British Columbia Cancer Agency Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

A Prospective Study of Hypertension and Arrhythmias in CLL Patients Treated With Bruton's Tyrosine Kinase Inhibitors
Conditions: Chronic Lymphocytic Leukemia; Atrial Fibrillation; Hypertension; Cardiotoxicity Interventions: Other: no intervention Sponsors: Abramson Cancer Center at Penn Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials